- Home
- Publications
- Publication Search
- Publication Details
Title
Mutational profile of ZBTB16‐RARA‐positive acute myeloid leukemia
Authors
Keywords
-
Journal
Cancer Medicine
Volume 10, Issue 12, Pages 3839-3847
Publisher
Wiley
Online
2021-05-27
DOI
10.1002/cam4.3904
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- APR-246 Combined with Azacitidine (AZA) in TP53 Mutated Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML). a Phase 2 Study By the Groupe Francophone Des Myélodysplasies (GFM)
- (2020) Thomas Cluzeau et al. BLOOD
- Classic and Variants APLs, as Viewed from a Therapy Response
- (2020) Marie-Claude Geoffroy et al. Cancers
- Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice
- (2019) Lin Han et al. LEUKEMIA
- Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers
- (2019) Hideaki Ogiwara et al. CANCER CELL
- Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet
- (2019) Miguel A. Sanz et al. BLOOD
- Mutational landscape of patients with acute promyelocytic leukemia at diagnosis and relapse
- (2019) Licia Iaccarino et al. AMERICAN JOURNAL OF HEMATOLOGY
- Efficacy of glutathione inhibitors for the treatment of ARID1A-deficient diffuse-type gastric cancers
- (2019) Mariko Sasaki et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial
- (2018) Nigel Russell et al. BLOOD
- Molecular landscape of acute promyelocytic leukemia at diagnosis and relapse
- (2017) Annette Fasan et al. HAEMATOLOGICA
- A novel genetic and morphologic phenotype of ARID2-mediated myelodysplasia
- (2017) H Sakai et al. LEUKEMIA
- Molecular landscape of acute promyelocytic leukemia at diagnosis and relapse
- (2017) Annette Fasan et al. HAEMATOLOGICA
- Current management of newly diagnosed acute promyelocytic leukemia
- (2016) L. Cicconi et al. ANNALS OF ONCOLOGY
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
- (2016) D. A. Arber et al. BLOOD
- Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia
- (2016) V Madan et al. LEUKEMIA
- Targeting of Mutant p53 and the Cellular Redox Balance by APR-246 as a Strategy for Efficient Cancer Therapy
- (2016) Vladimir J. N. Bykov et al. Frontiers in Oncology
- Recurrent CDKN1B (p27) mutations in hairy cell leukemia
- (2015) S. Dietrich et al. BLOOD
- Non-coding recurrent mutations in chronic lymphocytic leukaemia
- (2015) Xose S. Puente et al. NATURE
- Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis
- (2015) Claudio Luchini et al. Oncotarget
- Comparison of Newly Diagnosed and Relapsed Patients with Acute Promyelocytic Leukemia Treated with Arsenic Trioxide: Insight into Mechanisms of Resistance
- (2015) Ezhilarasi Chendamarai et al. PLoS One
- Understanding the molecular pathogenesis of acute promyelocytic leukemia
- (2014) Francesco Lo-Coco et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Essential role of BRG, the ATPase subunit of BAF chromatin remodeling complexes, in leukemia maintenance
- (2014) M. Buscarlet et al. BLOOD
- Activation of a promyelocytic leukemia–tumor protein 53 axis underlies acute promyelocytic leukemia cure
- (2014) Julien Ablain et al. NATURE MEDICINE
- Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation
- (2013) J. Shi et al. GENES & DEVELOPMENT
- Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
- (2013) Francesco Lo-Coco et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Landscape of Driver Mutations in Melanoma
- (2012) Eran Hodis et al. CELL
- The landscape of cancer genes and mutational processes in breast cancer
- (2012) Philip J. Stephens et al. NATURE
- ARID1A Mutations in Cancer: Another Epigenetic Tumor Suppressor?
- (2012) Jennifer N. Wu et al. Cancer Discovery
- Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma
- (2011) Meng Li et al. NATURE GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More